| Literature DB >> 18631391 |
Andres Kriete1, Kelli L Mayo, Nirupama Yalamanchili, William Beggs, Patrick Bender, Csaba Kari, Ulrich Rodeck.
Abstract
BACKGROUND: Chronic inflammation is a well-known corollary of the aging process and is believed to significantly contribute to morbidity and mortality of many age-associated chronic diseases. However, the mechanisms that cause age-associated inflammatory changes are not well understood. Particularly, the contribution of cell stress responses to age-associated inflammation in 'non-inflammatory' cells remains poorly defined. The present cross-sectional study focused on differences in molecular signatures indicative of inflammatory states associated with biological aging of human fibroblasts from donors aged 22 to 92 years.Entities:
Year: 2008 PMID: 18631391 PMCID: PMC2483950 DOI: 10.1186/1742-4933-5-5
Source DB: PubMed Journal: Immun Ageing ISSN: 1742-4933 Impact factor: 6.400
Figure 1NF-κB activity. Shown are the results of a DNA binding assay of the NF-κB p65 transcription factor, using two biological replicates and four readouts for each sample. NF-κB activity, a key mediator of inflammation, is elevated in the nuclear fractions of fibroblasts from the group of older donors compared to young donors (p < 0.005). The DNA binding activity corresponds to a "low-grade" inflammatory state compared to the TNFα treated positive control.
Figure 2Heatmap of gene-expression of inflammatory markers. Green indicates repressed mRNA levels and red elevated levels. Intensities are normalized for each gene in each row. Samples and genes are grouped according to their similarity in profile, included is Nf-κB activity in the first row. The dendrogram reveals distinct clusters preferentially grouping cytokines, chemokines and interferon related molecules, specifically expressed in each cell strain. Samples of young donors are distinct from the group of older donors, and the samples of the 68 and 86 old donors are distinct within the group of older donors.
List of inflammatory genes. Given are accession numbers of genes, fold changes and p-values between the group of older and young donors, a Pearson correlation coefficient (R) expressing similarity to the NF-κB profile as seen in Figure 1, and a description of genes.
| NM_001733 | 2.3 | 0.023 | 0.74 | complement component 1, r subcomponent (C1R) |
| NM_005438 | 2.0 | 0.033 | 0.71 | FOS-like antigen 1 (FOSL1) |
| NM_000732 | 2.0 | 0.012 | 0.69 | CD3D antigen, delta polypeptide (TiT3 complex) (CD3D) |
| NM_000586 | 4.6 | 0.020 | 0.68 | interleukin 2 (IL2) |
| NM_004591 | 2.0 | 0.068 | 0.65 | chemokine (C-C motif) ligand 20 (CCL20) |
| NM_005218 | 2.1 | 0.066 | 0.61 | defensin, beta 1 (DEFB1) |
| NM_002993 | 2.0 | 0.097 | 0.58 | chemokine (C-X-C motif) ligand 6 (granulocyte chemotactic protein 2) (CXCL6) |
| NM_003034 | 2.8 | 0.040 | 0.58 | sialyltransferase 8A (GD3 synthase) (SIAT8A) |
| NM_002127 | 3.5 | 0.104 | 0.56 | HLA-G histocompatibility antigen, class I, G (HLA-G) |
| NM_006644 | 2.6 | 0.102 | 0.52 | heat shock 105 kDa/110 kDa protein 1 (HSPH1) |
| NM_080741 | 6.1 | 0.093 | 0.49 | sialidase 4 (NEU4) |
| NM_002089 | 2.4 | 0.020 | 0.46 | chemokine (C-X-C motif) ligand 2 (CXCL2) |
| NM_001928 | 5.6 | 0.094 | 0.45 | D component of complement (adipsin) (DF) |
| NM_001937 | 2.2 | 0.017 | 0.41 | dermatopontin (DPT) |
| NM_000634 | 4.3 | 0.068 | 0.39 | interleukin 8 receptor, alpha (IL8RA) |
| NM_004887 | 3.5 | 0.047 | 0.38 | chemokine (C-X-C motif) ligand 14 (CXCL14) |
| NM_024298 | 6.8 | 0.023 | 0.30 | leukocyte receptor cluster (LRC) member 4 (LENG4) |
| NM_002416 | 3.6 | 0.068 | 0.22 | chemokine (C-X-C motif) ligand 9 (CXCL9) |
| NM_006573 | 3.3 | 0.040 | 0.17 | tumor necrosis factor (ligand) superfamily, member 13b (TNFSF13B) |
| NM_000575 | 2.7 | 0.033 | 0.17 | interleukin 1, alpha (IL1A) |
| NM_003641 | 2.0 | 0.088 | 0.13 | interferon induced transmembrane protein 1 (9–27) (IFITM1) |
| NM_000888 | 3.2 | 0.042 | 0.09 | integrin, beta 6 (ITGB6) |
| NM_005521 | 2.0 | 0.094 | 0.06 | T-cell leukemia, homeobox 1 (TLX1) |
| NM_004031 | 2.0 | 0.064 | 0.05 | interferon regulatory factor 7 (IRF7), transcript variant d |
| NM_000716 | 2.2 | 0.085 | 0.05 | complement component 4 binding protein, beta (C4BPB) |
| NM_007112 | 4.7 | 0.073 | 0.04 | thrombospondin 3 (THBS3) |
| NM_182764 | 3.4 | 0.061 | 0.04 | engulfment and cell motility 2 (ELMO2), transcript variant 3 |
| NM_207517 | 2.7 | 0.041 | 0.01 | ADAMTS-like 3 (ADAMTSL3) |
| NM_148962 | 4.8 | 0.083 | -0.03 | oxoeicosanoid (OXE) receptor 1 (OXER1) |
| NM_002427 | 5.1 | 0.093 | -0.11 | matrix metalloproteinase 13 (collagenase 3) (MMP13) |
| NM_000570 | 3.3 | 0.094 | -0.15 | Fc fragment of IgG, low affinity IIIb, receptor for (CD16) (FCGR3B) |
| NM_000577 | 2.7 | 0.116 | -0.19 | interleukin 1 receptor antagonist (IL1RN), transcript variant 3 |
| NM_000603 | 2.4 | 0.088 | -0.21 | nitric oxide synthase 3 (endothelial cell) (NOS3) |
| NM_002177 | 2.3 | 0.127 | -0.33 | interferon, omega 1 (IFNW1) |